Nifty

:

25884.80

Sensex

:

84587.01

-74.70 (-0.29%)
-313.70 (-0.37%)

Login

Nifty
Sensex

:
:

25884.80
84587.01

-74.70 (-0.29%)
-313.70 (-0.37%)

Jenburkt Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

69/99

BSE: 524731 | NSE: Not Listed

Watchlist

NSE BSE

1176.20

25-Nov-2025

Open
High
Low
Previous Close

1185
1195
1140
1193.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1310
1527121
1195
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

519.09
15.73
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

509.44
1.53%
2.84

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.95
6.78
3.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.39
15.28
5.87

PAT CAGR (%)

10 Years
5 Years
3 Years

11.52
14.21
9.22

P:E (Median)

8 Years
5 Years
3 Years

12.99
13.29
14.29

P:BV (Average)

8 Years
5 Years
3 Years

2.46
2.52
2.72

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.56
7.72
8.68

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 45.56 41.22 10.53% 35.53 32.54 9.19% 41.05 38.84 5.69% 36.89 35.66 3.45%
Expenses 32.45 29.79 8.93% 26.57 23.25 14.28% 30.19 28.99 4.14% 28.07 28.47 -1.40%
EBITDA 13.10 11.43 14.61% 8.96 9.29 -3.55% 10.86 9.85 10.25% 8.82 7.19 22.67%
EBIDTM 28.76% 27.72% 25.21% 28.55% 26.45% 25.37% 23.91% 20.17%
Other Income 2.08 1.85 12.43% 2.06 1.41 46.10% 1.88 1.19 57.98% 1.58 1.35 17.04%
Interest 0.11 0.12 -8.33% 0.11 0.12 -8.33% 0.11 0.06 83.33% 0.11 0.07 57.14%
Depreciation 0.74 0.64 15.62% 0.72 0.52 38.46% 0.79 0.62 27.42% 0.78 0.63 23.81%
PBT 14.33 12.52 14.46% 10.18 10.06 1.19% 11.83 10.37 14.08% 9.51 7.84 21.30%
Tax 4.17 2.92 42.81% 2.39 2.65 -9.81% 3.30 2.48 33.06% 3.01 2.44 23.36%
PAT 10.16 9.60 5.83% 7.79 7.42 4.99% 8.54 7.88 8.38% 6.51 5.40 20.56%
PATM 22.31% 23.30% 21.94% 22.79% 20.80% 20.30% 17.64% 15.15%
EPS 23.10 21.82 5.87% 17.71 16.85 5.10% 19.40 17.92 8.26% 14.79 12.28 20.44%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 159.03 151.69 141.97 136.75 123.98 109.29 118.89 122.64 114.67 103.31 93.59 Net Sales Growth 7.26% 6.85% 3.82% 10.30% 13.44% -8.07% -3.06% 6.95% 11.00% 10.39% Cost Of Goods Sold 29.97 25.94 26.60 28.55 27.45 27.72 30.06 33.13 31.18 27.84 25.47 Gross Profit 129.06 125.75 115.37 108.20 96.53 81.57 88.83 89.52 83.49 75.47 68.11 GP Margin 81.16% 82.90% 81.26% 79.12% 77.86% 74.64% 74.72% 72.99% 72.81% 73.05% 72.77% Total Expenditure 117.28 111.30 108.85 106.38 96.73 89.45 99.15 97.72 90.89 83.59 77.13 Power & Fuel Cost - 0.71 0.75 0.76 0.61 0.50 0.59 0.59 0.61 0.53 0.57 % Of Sales - 0.47% 0.53% 0.56% 0.49% 0.46% 0.50% 0.48% 0.53% 0.51% 0.61% Employee Cost - 45.54 42.49 38.81 36.49 32.38 36.51 31.20 27.69 25.21 21.49 % Of Sales - 30.02% 29.93% 28.38% 29.43% 29.63% 30.71% 25.44% 24.15% 24.40% 22.96% Manufacturing Exp. - 5.30 5.77 6.49 5.70 3.70 4.45 4.76 4.05 3.92 4.22 % Of Sales - 3.49% 4.06% 4.75% 4.60% 3.39% 3.74% 3.88% 3.53% 3.79% 4.51% General & Admin Exp. - 16.28 15.99 15.14 6.46 7.12 8.27 10.48 10.36 9.78 8.77 % Of Sales - 10.73% 11.26% 11.07% 5.21% 6.51% 6.96% 8.55% 9.03% 9.47% 9.37% Selling & Distn. Exp. - 16.70 16.68 16.14 20.00 17.08 18.72 17.21 16.55 16.00 16.61 % Of Sales - 11.01% 11.75% 11.80% 16.13% 15.63% 15.75% 14.03% 14.43% 15.49% 17.75% Miscellaneous Exp. - 0.83 0.58 0.50 0.01 0.95 0.54 0.35 0.45 0.31 16.61 % Of Sales - 0.55% 0.41% 0.37% 0.01% 0.87% 0.45% 0.29% 0.39% 0.30% 0% EBITDA 41.74 40.39 33.12 30.37 27.25 19.84 19.74 24.92 23.78 19.72 16.46 EBITDA Margin 26.25% 26.63% 23.33% 22.21% 21.98% 18.15% 16.60% 20.32% 20.74% 19.09% 17.59% Other Income 7.60 6.72 4.67 5.12 4.95 4.31 4.22 3.45 3.39 2.96 2.73 Interest 0.44 0.45 0.27 0.37 0.43 0.47 0.53 0.39 0.41 0.41 0.38 Depreciation 3.03 2.73 2.34 2.26 1.90 2.04 2.30 1.35 1.50 1.79 1.99 PBT 45.85 43.93 35.18 32.86 29.87 21.64 21.14 26.63 25.27 20.48 16.82 Tax 12.87 11.87 9.20 8.26 7.57 5.14 6.27 6.84 8.06 6.97 6.05 Tax Rate 28.07% 27.02% 26.15% 25.14% 25.34% 23.75% 29.66% 25.69% 31.90% 34.03% 35.95% PAT 33.00 32.06 25.98 24.61 22.30 16.50 14.87 19.80 17.21 13.51 10.78 PAT before Minority Interest 33.00 32.06 25.98 24.61 22.30 16.50 14.87 19.80 17.21 13.51 10.78 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.75% 21.14% 18.30% 18.00% 17.99% 15.10% 12.51% 16.14% 15.01% 13.08% 11.52% PAT Growth 8.91% 23.40% 5.57% 10.36% 35.15% 10.96% -24.90% 15.05% 27.39% 25.32% EPS 75.00 72.86 59.05 55.93 50.68 37.50 33.80 45.00 39.11 30.70 24.50

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 171.78 144.94 122.39 117.38 98.47 80.00 77.47 61.26 54.44 40.19 Share Capital 4.41 4.41 4.41 4.59 4.59 4.59 4.59 4.59 4.65 4.65 Total Reserves 167.36 140.53 117.98 112.79 93.88 75.41 72.88 56.67 49.79 35.54 Non-Current Liabilities 4.12 2.98 3.24 3.92 3.99 4.50 -0.37 3.14 3.67 3.76 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.24 0.25 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 18.82 16.38 15.76 21.28 17.99 19.89 25.44 13.15 18.30 14.08 Trade Payables 8.16 6.26 6.10 7.11 4.59 5.23 6.55 4.12 6.02 3.30 Other Current Liabilities 6.80 7.55 6.63 8.02 8.22 8.52 10.79 8.67 5.45 4.67 Short Term Borrowings 1.98 0.00 2.44 5.82 3.71 3.44 7.47 0.01 6.13 5.17 Short Term Provisions 1.89 2.57 0.59 0.34 1.47 2.70 0.63 0.36 0.70 0.93 Total Liabilities 194.72 164.30 141.39 142.58 120.45 104.39 102.54 77.55 76.41 58.03 Net Block 14.66 10.36 10.45 11.40 10.55 11.73 9.59 9.57 10.63 12.11 Gross Block 40.38 33.86 33.99 33.47 31.97 31.31 26.89 25.69 25.45 25.54 Accumulated Depreciation 25.72 23.50 23.54 22.07 21.42 19.58 17.30 16.12 14.83 13.44 Non Current Assets 138.19 54.57 60.30 66.67 40.46 14.77 12.79 11.55 12.52 12.72 Capital Work in Progress 40.28 1.24 0.96 0.21 0.38 0.12 0.99 0.00 0.00 0.00 Non Current Investment 20.56 16.79 11.18 7.96 6.50 2.50 1.86 1.63 1.39 0.61 Long Term Loans & Adv. 2.08 25.36 11.55 11.49 0.32 0.29 0.17 0.10 0.26 0.00 Other Non Current Assets 60.61 0.82 26.16 35.61 22.71 0.13 0.18 0.25 0.25 0.00 Current Assets 56.53 109.73 81.09 75.90 79.99 89.63 89.75 66.01 63.89 45.31 Current Investments 0.00 0.00 0.00 0.00 0.25 1.57 3.52 3.79 0.55 0.00 Inventories 8.88 8.56 8.34 9.89 7.58 10.90 9.83 6.80 10.75 8.24 Sundry Debtors 20.73 19.48 16.96 15.21 14.00 17.83 22.89 12.54 9.07 5.78 Cash & Bank 24.65 79.19 53.81 49.02 56.51 57.69 51.70 41.11 42.08 29.64 Other Current Assets 2.27 0.96 0.97 0.73 1.65 1.63 1.81 1.77 1.44 1.66 Short Term Loans & Adv. 0.98 1.54 1.01 1.05 1.02 0.78 1.02 0.97 0.81 0.53 Net Current Assets 37.71 93.35 65.33 54.62 62.00 69.74 64.31 52.85 45.59 31.23 Total Assets 194.72 164.30 141.39 142.57 120.45 104.40 102.54 77.56 76.41 58.03

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 27.91 8.12 17.05 9.27 19.45 15.02 12.99 16.18 9.95 7.82 PBT 43.93 35.09 32.86 29.87 21.64 21.14 26.63 25.27 20.48 16.83 Adjustment -3.09 -0.49 -1.54 -2.25 -1.60 -1.22 -1.65 -1.67 -0.74 -0.50 Changes in Working Capital 0.49 -18.22 -6.05 -10.79 5.25 0.57 -4.90 0.97 -3.01 -2.76 Cash after chg. in Working capital 41.34 16.39 25.28 16.83 25.29 20.48 20.08 24.57 16.72 13.57 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -13.43 -8.26 -8.22 -7.56 -5.84 -5.46 -7.10 -8.39 -6.77 -5.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -17.04 -0.58 2.62 -1.20 -18.78 -2.88 -10.53 1.00 -9.77 -0.27 Net Fixed Assets -45.56 -0.15 -1.27 -1.33 -0.92 -3.55 -2.19 -0.24 0.09 -2.05 Net Investments -3.77 -5.61 -3.22 -1.21 -2.68 1.31 0.04 -3.48 -1.33 -0.30 Others 32.29 5.18 7.11 1.34 -15.18 -0.64 -8.38 4.72 -8.53 2.08 Cash from Financing Activity -7.62 -7.08 -21.04 -5.53 -0.71 -10.83 -2.42 -17.98 0.68 -5.42 Net Cash Inflow / Outflow 3.24 0.47 -1.37 2.54 -0.04 1.31 0.04 -0.80 0.86 2.13 Opening Cash & Equivalents 4.13 3.66 5.03 2.49 2.53 1.23 1.18 1.99 1.13 27.51 Closing Cash & Equivalent 7.36 4.13 3.66 5.03 2.49 2.53 1.23 1.18 1.99 29.64

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 389.23 328.42 277.32 255.77 214.55 174.32 168.79 133.48 117.09 86.44 ROA 17.86% 17.00% 17.33% 16.95% 14.68% 14.37% 21.99% 22.36% 20.10% 18.13% ROE 20.25% 19.43% 20.53% 20.66% 18.49% 18.89% 28.54% 29.75% 28.55% 29.28% ROCE 27.85% 26.28% 26.80% 26.89% 23.83% 25.73% 36.90% 41.99% 39.26% 40.17% Fixed Asset Turnover 4.09 4.18 4.05 3.79 3.45 4.09 4.66 4.50 4.11 3.87 Receivable days 48.38 46.84 42.93 42.99 53.15 62.51 52.73 34.30 25.83 25.28 Inventory Days 20.98 21.72 24.32 25.71 30.86 31.82 24.75 27.85 33.02 30.41 Payable days 101.38 84.76 84.44 77.81 64.63 71.48 21.37 23.54 22.02 18.13 Cash Conversion Cycle -32.02 -16.20 -17.19 -9.11 19.38 22.85 56.11 38.61 36.83 37.56 Total Debt/Equity 0.01 0.00 0.02 0.05 0.04 0.04 0.10 0.00 0.12 0.13 Interest Cover 98.02 130.99 90.55 69.76 46.69 41.22 70.02 62.32 50.96 45.51

Top Investors:

nirmala vinodkumar daga

investor education and protection fund authority

ranjeet singh sibia

sushila paraskumar daga

parshva kumar daga

Annual Reports:

News Update:

Jenburkt Pharma - Quarterly Results
29th Oct 2025, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback